NK cells in host defense against invasive aspergillosis
NK 细胞在宿主防御侵袭性曲霉病中的作用
基本信息
- 批准号:7250078
- 负责人:
- 金额:$ 28.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-11 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllogenicAntifungal AgentsAspergillosisAspergillusBiologyCellsClassComplicationCytolysisDevelopmentEffector CellHost DefenseHyphaeImmune responseImmunityImmunosuppressionIn VitroIndividualInfectionInterferon Type IIInterferonsInvasiveLaboratoriesLigandsLungLymphocyte SubsetMediatingMediator of activation proteinModelingMusNatural Killer CellsOrganismOutcomePhagocytesProductionRateRoleSourceTestingTherapeutic immunosuppressionTransplantationWorkantimicrobialbeta-Chemokineschemokinechemokine receptorimprovedin vivoinsightmonocyte chemoattractant protein 1 receptorneoplastic cellneutrophilnovelpathogenresponse
项目摘要
DESCRIPTION (provided by applicant): Invasive pulmonary aspergillosis, a common complication of immunosuppression, carries a strikingly poor outcome despite currently available therapy. While substantial work has evaluated the role of neutrophils in the lung's innate immune response to this pathogen, the role of other effector cells in host defense against this organism is less clear. Natural killer (NK) cells are a subset of lymphocytes important in immune responses against tumor cells, transplanted allogeneic cells, and several classes of micro-organisms. Our preliminary studies indicate that NK cells are critical to host survival in neutropenic mice with invasive aspergillosis and that their recruitment to the lung in the setting of this infection may be mediated by the CC chemokine ligand, MCP-1/CCL2. Moreover, NK cell-derived interferon-gamma (IFN-gamma) appears to augment fungal clearance from the lung. We therefore hypothesize that NK cells are integral components of innate host defense against invasive aspergillosis in neutropenic hosts, and that enhancing the recruitment of NK cells to the lung or augmenting their effector functions will improve the outcome of invasive aspergillosis. We shall address these hypotheses by examining the following Specific Aims in a murine model of invasive pulmonary aspergillosis: 1) To determine the in vitro activity of NK cells against Aspergillus and to determine their in vivo contribution to host defense in invasive aspergillosis; 2) To examine the role of the chemokine ligand, MCP-1/CCL2, and its receptor, CCR2, in the recruitment of NK cells to the lungs in invasive aspergillosis; and 3) To evaluate the role of NK cell-derived IFN-gamma in mediating anti-fungal host defense in vitro and in vivo. We hope that the proposed studies will provide important new insights into the role of NK cells as mediators of innate host defense in the lung in invasive aspergillosis, and that they will also result in development of novel therapies for this devastating infection.
描述(由申请人提供):侵袭性肺曲霉菌病是免疫抑制的常见并发症,尽管目前有治疗方法,但预后极差。 虽然大量的工作已经评估了中性粒细胞在肺对这种病原体的先天免疫应答中的作用,但其他效应细胞在宿主防御这种生物体中的作用尚不清楚。 自然杀伤(NK)细胞是在针对肿瘤细胞、移植的同种异体细胞和几类微生物的免疫应答中重要的淋巴细胞的子集。 我们的初步研究表明,NK细胞是至关重要的宿主生存在侵袭性曲霉菌感染的小鼠,并在这种感染的设置,其招聘到肺可能是由CC趋化因子配体,MCP-1/CCL 2介导的。 此外,NK细胞衍生的干扰素-γ(IFN-γ)似乎增加真菌从肺中的清除。 因此,我们假设NK细胞是先天性宿主防御侵袭性曲霉病的组成部分,并增强NK细胞的招募到肺或增强其效应功能,将改善侵袭性曲霉病的结果。 我们将通过在侵袭性肺曲霉菌病小鼠模型中检查以下具体目的来解决这些假设:1)确定NK细胞对曲霉菌的体外活性,并确定它们在侵袭性曲霉菌病中对宿主防御的体内贡献; 2)检测趋化因子配体MCP-1/CCL 2及其受体CCR 2在侵袭性曲霉病中NK细胞向肺募集中的作用; 3)研究NK细胞源性IFN-γ在体内外介导抗真菌宿主防御中的作用。 我们希望,拟议的研究将提供重要的新见解NK细胞作为介质的先天性宿主防御在肺部侵袭性曲霉菌病的作用,他们也将导致开发新的疗法,这种毁灭性的感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Borna Mehrad其他文献
Borna Mehrad的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Borna Mehrad', 18)}}的其他基金
Neutrophils and adaptive immunity against invasive aspergillosis
中性粒细胞和针对侵袭性曲霉病的适应性免疫
- 批准号:
8996132 - 财政年份:2015
- 资助金额:
$ 28.73万 - 项目类别:
NK cells in host defense against invasive aspergillosis
NK 细胞在宿主防御侵袭性曲霉病中的作用
- 批准号:
7337024 - 财政年份:2003
- 资助金额:
$ 28.73万 - 项目类别:
NK cells in host defense against invasive aspergillosis
NK 细胞在宿主防御侵袭性曲霉病中的作用
- 批准号:
7654277 - 财政年份:2003
- 资助金额:
$ 28.73万 - 项目类别:
NK cells in host defense against invasive aspergillosis
NK 细胞在宿主防御侵袭性曲霉病中的作用
- 批准号:
7849622 - 财政年份:2003
- 资助金额:
$ 28.73万 - 项目类别:
相似海外基金
HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
- 批准号:
10039902 - 财政年份:2022
- 资助金额:
$ 28.73万 - 项目类别:
EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
- 批准号:
21K15925 - 财政年份:2021
- 资助金额:
$ 28.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
- 批准号:
21K08410 - 财政年份:2021
- 资助金额:
$ 28.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
- 批准号:
20K21672 - 财政年份:2020
- 资助金额:
$ 28.73万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
- 批准号:
18K16395 - 财政年份:2018
- 资助金额:
$ 28.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
- 批准号:
17K10951 - 财政年份:2017
- 资助金额:
$ 28.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
- 批准号:
370541 - 财政年份:2017
- 资助金额:
$ 28.73万 - 项目类别:
Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
- 批准号:
16K10863 - 财政年份:2016
- 资助金额:
$ 28.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
- 批准号:
276706135 - 财政年份:2015
- 资助金额:
$ 28.73万 - 项目类别:
Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
- 批准号:
15H04915 - 财政年份:2015
- 资助金额:
$ 28.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)